Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment
- PMID: 36867377
- DOI: 10.1007/s11912-023-01375-8
Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment
Abstract
Purpose of review: Testicular cancer (TC) is the leading cancer in men between 18 and 39 years of age. Current treatment involves tumor resection followed by surveillance and/or one or more lines of cisplatin-based chemotherapy (CBCT) and/or bone marrow transplant (BMT). Ten years after treatment, CBCT has been associated with significant atherosclerotic cardiovascular disease (CVD) including myocardial infarction (MI), stroke, and heightened rates of hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome (MetS). Additionally, low testosterone levels and hypogonadism contribute to MetS and may further drive CVD.
Recent findings: CVD in TCS has been associated with worse physical functioning accompanied by role limitations, decreased energy, and decreased overall health. Exercise may play a role in ameliorating these effects. Systematic CVD screening practices are needed at TC diagnosis and in survivorship. We encourage a multidisciplinary partnership between primary care physicians, cardiologists, cardio-oncologists, medical oncologists, and survivorship providers to address these needs.
Keywords: Cardiovascular disease; Hypertension; Platinum; Prevention; Survivorship; Testicular cancer.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.J Clin Oncol. 2023 Jul 1;41(19):3512-3522. doi: 10.1200/JCO.22.01016. Epub 2023 Apr 18. J Clin Oncol. 2023. PMID: 37071834 Free PMC article.
-
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.J Natl Compr Canc Netw. 2019 May 1;17(5):459-468. doi: 10.6004/jnccn.2018.7109. J Natl Compr Canc Netw. 2019. PMID: 31085753 Free PMC article.
-
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.Br J Cancer. 2013 Jul 9;109(1):60-7. doi: 10.1038/bjc.2013.226. Epub 2013 May 9. Br J Cancer. 2013. PMID: 23660945 Free PMC article.
-
Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.Curr Oncol Rep. 2021 May 3;23(7):77. doi: 10.1007/s11912-021-01066-2. Curr Oncol Rep. 2021. PMID: 33937943 Free PMC article. Review.
-
Testicular Cancer Survivorship.J Natl Compr Canc Netw. 2019 Dec;17(12):1557-1568. doi: 10.6004/jnccn.2019.7369. J Natl Compr Canc Netw. 2019. PMID: 31805527 Review.
Cited by
-
Testicular Cancer Treatments and Sexuality: A Narrative Review.Medicina (Kaunas). 2024 Mar 31;60(4):586. doi: 10.3390/medicina60040586. Medicina (Kaunas). 2024. PMID: 38674232 Free PMC article. Review.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- Testicular Cancer: Statistics, in Board CNE (ed): Testicular cancer guide, 2005–2022 American Society of Clinical Oncology (ASCO), 02/2022. https://www.cancer.net/cancer-types/testicular-cancer/statistics
-
- •• Lauritsen J, Hansen MK, Bandak M, Kreiberg MB, Skøtt JW, Wagner T, Gundgaard Kier MG, Holm NV, Agerbæk M, Gupta R, Dehlendorff C, Andersen KK, Daugaard G. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. J Clin Oncol. 2020;38(6):584-592. https://doi.org/10.1200/JCO.19.01180 . This well-designed thoughtful national cohort study has defined the prevalence of both cardiovascular risk factors and cardiovascular disease in testicular cancer survivorship.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials